Semaglutide Research Review: A Long-Acting GLP-1 Receptor Agonist for Metabolic Studies
A research-focused overview of semaglutide, an acylated GLP-1 receptor agonist engineered for weekly pharmacokinetics, covering its structural modifications, receptor mechanism, and glycemic and body-composition research endpoints.